Brain Diseases  >>  ponezumab (PF-04360365)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ponezumab (PF-04360365) / Pfizer
NCT00733642: Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Completed
1
15
US
PF-04360365 1 mg/kg, PF-04360365 3 mg/kg, PF-04360365 5 mg/kg, PF-04360365 10 mg/kg
Pfizer
Alzheimer's Disease
07/09
07/09
NCT00455000: A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

Completed
1
37
Canada, Europe, RoW
PF-04360365, Placebo
Pfizer
Alzheimer's Disease
09/09
09/09
NCT00607308: A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Completed
1
20
Japan
PF-04360365, Placebo
Pfizer
Alzheimer's Disease
10/10
10/10
NCT01125631: Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Completed
1
8
Japan
PF-04360365 8.5 mg/kg, Placebo
Pfizer
Alzheimer's Disease
08/11
08/11
NCT01005862: Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

Completed
1
17
US, Europe
PF-04360365, Placebo
Pfizer
Alzheimer's Disease
09/12
09/12

Download Options